In some ways MSB only survives still due to the shorts making $$ while providing capital for MSB to continue operations.
Might be why they say "Be careful what you wish for".
Of course, once MSB becomes profitable there will no longer be any need to raise capital.
Is it the shorters who are the enemy or the FDA stretching things out.
With ALL of the various companies running stem cell trials why is it only MSB being told not to run any trials util the MOA and batch consistency issues are sorted out? Hmmm?
Cell Therapy News/Articles, page-16780
-
- There are more pages in this discussion • 1,138 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 96.0¢ | $1.141M | 1.173M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 192210 | 96.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.5¢ | 47506 | 14 |
View Market Depth
| Last trade - 11.50am 13/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |